Elisa Longinetti

8PUBLICATIONS
11CO-AUTHORS
AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neurology and neuromuscular diseasesBiological adaptationPacific Peoples youth and family
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 14, 2024
Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy.

Simon Englund, Thomas Frisell, Ying Qu

|Aug 09, 2023
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.

Elisa Longinetti, Simon Englund, Joachim Burman

|Aug 22, 2022
COVID-19 clinical outcomes and DMT of MS patients and population-based controls.

Elisa Longinetti, Hannah Bower, Kyla A McKay

|Sep 27, 2021
Geographical clusters of amyotrophic lateral sclerosis and the Bradford Hill criteria.

Elisa Longinetti, Elisabetta Pupillo, Chiara Belometti

|Jul 23, 2021
Mortality among family members of patients with amyotrophic lateral sclerosis - a Swedish register-based study.

Ulf Kläppe, Elisa Longinetti, Henrik Larsson

|Jul 15, 2021
Risk of depression in multiple sclerosis across disease-modifying therapies.

Elisa Longinetti, Thomas Frisell, Simon Englund

Pageof 2